You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

CLINICAL TRIALS PROFILE FOR PF-05221304

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for PF-05221304

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT02871037 ↗	Single Dose, Repeated Dose, and Conditional Food Effect Study of PF-05221304 in Healthy Subjects	Completed	Pfizer	Phase 1	The current study is the first clinical trial proposed with PF-05221304. It is designed to evaluate the safety, tolerability, and pharmacokinetics (PK) following administration of single and repeated doses of PF-05221304 to healthy adult subjects. The study may also evaluate effect of food on PK of PF-05221304.
NCT03248882 ↗	Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)	Completed	Pfizer	Phase 2	Phase 2a, dose-ranging Study with PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)
NCT03309202 ↗	Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment	Completed	Pfizer	Phase 1	Hepatic impairment PK study
NCT03448172 ↗	Single-dose Study of [14C]PF-05221304 Metabolism and Excretion in Healthy Adult Male Subjects	Completed	Pfizer	Phase 1	The purpose of the study is to characterize the absorption, distribution, metabolism, and excretion (ADME) of a single oral dose of [14C]PF-05221304 in Healthy Adult Male Subjects
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for PF-05221304

Condition Name

Chart
Table

Condition Name
Intervention	Trials
Healthy	4
Nonalcoholic Fatty Liver Disease	3
Nonalcoholic Steatohepatitis	2
Nonalcoholic Steatohepatitis With Liver Fibrosis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH
Intervention	Trials
Liver Diseases	6
Fatty Liver	5
Non-alcoholic Fatty Liver Disease	5
Liver Cirrhosis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for PF-05221304

Trials by Country

Map
Table

Trials by Country
Location	Trials
United States	71
Canada	15
Japan	12
China	10
India	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State
Location	Trials
Florida	5
New York	4
California	4
Virginia	4
Texas	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for PF-05221304

Clinical Trial Phase

Chart
Table

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 2	4
Phase 1	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	8
Recruiting	2
Withdrawn	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PF-05221304

Sponsor Name

Chart
Table

Sponsor Name
Sponsor	Trials
Pfizer	11
Columbia University	1
Henry N. Ginsberg	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type
Sponsor	Trials
Industry	11
Other	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.